Unios Pharmaceuticals Private Limited
About Unios Pharmaceuticals Private Limited
Data last updated:
Unios Pharmaceuticals Private Limited is a private limited company based in Nagpur, Maharashtra, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 29 June 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Nagpur, under CIN U24290MH2020PTC341192. Its GSTIN is 10AACCU6096K2Z5 (Bihar). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Nishant Kumar and Amit Kumar Ray.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at H.No – 1058/3 Ward No – 3 Waddhamna Hingana., Nagpur, Maharashtra, India – 440023.
As per the financials filed for FY 2024, the company reported a revenue of ₹4.57 Lakh, a decline of 9% compared to the previous year. For the same year it recorded a net profit of ₹1,383 (net margin 0.3%) and EBITDA of ₹12,438 (EBITDA margin 2.7%). Revenue has grown at a compounded annual rate (CAGR) of 39% over three years.
Company details
Contact details
Unios Pharmaceuticals Private Limited's registered office is in Nagpur, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressH.No – 1058/3 Ward No – 3 Waddhamna Hingana., Nagpur, Maharashtra, India – 440023
- IndustryChemicals, Manufacturing, Other Chemical Product
To see the full contact details of Unios Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Unios Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Unios Pharmaceuticals Private Limited, buy the company report.
Financials of Unios Pharmaceuticals Private Limited
FY 2024 filings availableUnios Pharmaceuticals Private Limited reported revenue of ₹4.57 Lakh (down 9% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 9% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 39%. EBITDA rose 105% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹12,438 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹1,383 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 2.7% | |||
| Net Profit Margin | 0.3% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Unios Pharmaceuticals Private Limited, buy the company report.
Board of directors of Unios Pharmaceuticals Private Limited
Unios Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nishant Kumar | Director | 28 Jul 2022 | 4 Years 3 Months | Current |
| Amit Kumar Ray | Director | 29 Jun 2020 | 6 Years 3 Months | Current |
Peer comparison
Unios Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Medoc Pharmaceuticals Private Limited | ₹4.58 Lakh (FY 2024) | -12.0% | Delhi, India | |||
| Steadymed Pharmaceuticals Private Limited | ₹4.58 Lakh (FY 2023) | -22.0% | Kolkata, West Bengal, India | |||
| Neurolife Pharmaceuticals Private Limited | ₹4.58 Lakh (FY 2020) | 131.0% | Palampur, Himachal Pradesh, India | |||
| Unios Pharmaceuticals Private Limitedthis company | ₹4.57 Lakh (FY 2024) | ₹1,383 | 0.3% | -9.0% | Nagpur, Maharashtra, India | |
| Wellbecure Pharmaceuticals Private Limited | ₹4.57 Lakh (FY 2025) | 14.0% | Varanasi, Uttar Pradesh, India | |||
| Accost Pharmaceuticals (India) Private Limited | ₹4.57 Lakh (FY 2024) | -27.0% | Rajendra Nagar, Patna, Bihar, India | |||
| Dare and Vision Pharmaceuticals Private Limited | ₹4.56 Lakh (FY 2024) | 72.0% | Jabalpur, Madhya Pradesh, India |
To see the full peer comparison of Unios Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Unios Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Unios Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Unios Pharmaceuticals Private Limited has 1 active EPFO establishment as of Mar 30, 2024.
GST
Unios Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AACCU6096K2Z5 | Bihar | Active | 20 Jan 2021 |
To see the full GST registrations and return filing status of Unios Pharmaceuticals Private Limited, buy the company report.
Recent activity
Unios Pharmaceuticals Private Limited has 6 board changes on record since 2020: 4 appointments and 2 cessations. The latest: Mujibur Rahman ceased to be Director on 30 Jul 2022.
Frequently asked questions
Unios Pharmaceuticals is an active private limited company based in Nagpur, Maharashtra, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 29 June 2020 (6+ years old) and is registered under CIN U24290MH2020PTC341192.
Unios Pharmaceuticals has 2 current directors:
- Nishant Kumar - Director
- Amit Kumar Ray - Director
The latest financial statements of Unios Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Unios Pharmaceuticals is 10AACCU6096K2Z5, registered in Bihar. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Unios Pharmaceuticals is U24290MH2020PTC341192. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Unios Pharmaceuticals was incorporated on 29 June 2020, making it 6+ years old. It is registered with the Registrar of Companies, Nagpur.
The peers of Unios Pharmaceuticals by revenue are Medoc Pharmaceuticals Private Limited, Steadymed Pharmaceuticals Private Limited, Neurolife Pharmaceuticals Private Limited, Wellbecure Pharmaceuticals Private Limited, Accost Pharmaceuticals (India) Private Limited and 1 more, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Mujibur Rahman ceased to be Director on 30 Jul 2022. Rakesh Kumar ceased to be Director on 30 Jul 2022. Nishant Kumar was appointed as Director on 28 Jul 2022. Unios Pharmaceuticals has 6 board changes on record in total.
The registered office of Unios Pharmaceuticals is at H.No – 10583 Ward No – 3 Waddhamna Hingana., Nagpur, Maharashtra, India – 440023.
Unios Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
Unios Pharmaceuticals can be reached at its registered office: H.No – 10583 Ward No – 3 Waddhamna Hingana, Nagpur, Maharashtra, India – 440023.